Skip to content

Application of Telemedicine for Dermatological Emergency Patients

Application of Telemedicine for Dermatological Emergency Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02836665
Acronym
Telederm
Enrollment
100
Registered
2016-07-19
Start date
2016-08-31
Completion date
2017-12-31
Last updated
2018-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatological Emergency

Keywords

Emergency Room, Manchester Triage System, Telemedicine, Patients

Brief summary

After admission to the emergency room each dermatological patient is routinely assessed to Manchester Triage System (MTS) by the nursing staff. Thereby data are collected for anamnesis followed by randomization in two equal study groups. Patients of group A (control group) wait routinely until the dermatological investigator in charge arrives at the emergency room. Once the dermatological investigator is on site, he gives a diagnosis and proposes a therapy. For Patients of group B (teledermatology) study-related photographs of the skin lesion and anamnesis data are uploaded to the hospital information system medico. Those data can directly be processed by the dermatological investigator in charge who enters his diagnosis and his therapy proposal. Subsequently an internal control is carried out as the same investigator comes personally to the emergency room to check its telemedical diagnosis and therapy proposal. Finally both time periods patients have to wait in the emergency room for their diagnosis and therapy are compared with each other.

Detailed description

After admission to the emergency room each dermatological patient is routinely assessed to Manchester Triage System (MTS) by the nursing staff. Thereby data are collected for anamnesis (duration of symptoms, allergies, self-medication, medical history) followed by randomization in two equal study groups. Patients of group A (control group) wait routinely until the dermatological investigator in charge arrives at the emergency room. Once the dermatological investigator is on site, he gives a diagnosis and proposes a therapy. Time is measured from the patients admission to the emergency room up to the personnel diagnosis and therapy by the dermatological investigator in charge. For Patients of group B (teledermatology) first of all study-related photographs of the skin lesions are taken with a tablet. After that the registration of the consult teledermatology is carried out by the emergency investigator in charge, who uploads the photographs as well as the data for anamnesis to the hospital information system medico. The consult teledermatology can directly be processed by the dermatological investigator in charge who enters his diagnosis and his therapy proposal. Time is measured from admission to the emergency room up to the telemedical diagnosis and therapy by the dermatological investigator in charge. Subsequently an internal control is carried out as the same investigator comes personally to the emergency room to check its telemedical diagnosis and therapy proposal. Finally both time measurements are compared with each other.

Interventions

PROCEDURETelemedicine for dermatological emergency patients

Study-related photographs of the skin lesion made by a tablet and anamnesis data are uploaded to the hospital information system medico. Those data can directly be processed by the dermatological investigator in charge who enters his diagnosis and his therapy proposal without being on site.

Sponsors

RWTH Aachen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female aged ≥ 18 years * Written informed consent prior to study participation * Adults who are contractually capable and mentally able to understand and follow the instructions of the study personnel. * Dermatological emergency patient

Exclusion criteria

* Male or female aged \< 18 years * Missing informed consent prior to study participation * Patient has been committed to an institution by legal or regulatory order * Persons in dependence from the sponsor or working with the sponsor * Participation in another clinical trial within the previous 2 months

Design outcomes

Primary

MeasureTime frameDescription
Waiting time [min]1 emergency visit [approximately 2 hours]Time is measured from the patients admission to the emergency room up to the personnel/telemedical diagnosis and therapy by the dermatological investigator in charge.

Secondary

MeasureTime frameDescription
Number of differences between the personally and the telemedical diagnosis and therapy proposal1 emergency visit [approximately 2 hours]An internal control is carried out as the same investigator comes personally to the emergency room to check its telemedical diagnosis and therapy proposal.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026